No definition available.
Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
DOID EFO Endpoint Browser PheWeb
O15_MATERN_INFECT_ELSEWHERE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
807 |
4. Check minimum number of eventsNone |
807 |
5. Include endpointsNone |
807 |
6. Filter based on genotype QC (FinnGen only) |
807 |
Control definitions (FinnGen only)
- Control exclude
- O15_OBSTET_NAS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- O94-O99
- Name in latin
- Morbi infectiosi et parasitici materni alibi classificabiles sed complicantes graviditatem, partum et puerperium
Similar endpoints
↥List of similar endpoints to
Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
based on the number of shared cases.
Similar with more cases:
- Other obstetric conditions, not elsewhere classified
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6905 | 6905 | - |
| Only index persons | 6801 | 6801 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.20 | 0.20 | - |
| Only index persons | 0.25 | 0.25 | - |
| Median age at first event (years) | |||
| Whole population | - | 29.22 | - |
| Only index persons | - | 29.24 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 807 | 807 | - |
| Unadjusted period prevalence (%) | 0.28 | 0.28 | - |
| Median age at first event (years) | 29.43 | 29.43 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 743
- Matched controls
- 7430
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
O98.8
ICD-10 Finland
Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium
+∞
142.4
132
*
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
+∞
134.6
125
*
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
+∞
134.6
125
*
O98.3
ICD-10 Finland
Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium
+∞
127.9
119
*
O99.80
ICD-10 Finland
The fear of childbirth
+∞
99.2
93
*
6478X
ICD-9 Finland
Infective and parasitic conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other specified infective and parasitic diseases
+∞
84.0
79
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
33.7
80.0
105
36
6476A
ICD-9 Finland
Infective and parasitic conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other viral diseases
+∞
64.5
61
*
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
4.8
62.0
246
691
O98.9
ICD-10 Finland
Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium
+∞
61.3
58
*
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
321.9
59.2
59
*
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
3.2
44.7
324
1444
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.9
40.8
146
351
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
144.4
39.1
41
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
3.6
38.8
209
728
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
2.9
38.3
322
1543
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
53.1
38.0
45
9
Z72.2
ICD-10 Finland
Drug use
63.4
36.5
42
7
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
177.9
33.0
34
*
P19
ICPC
Drug abuse
19.9
30.0
45
24
O80.0
ICD-10 Finland
Spontaneous vertex delivery
2.4
29.5
456
2932
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
10.9
29.5
57
56
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
59.2
29.4
34
6
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
2.8
27.9
221
977
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.4
27.4
403
2487
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
39.5
27.3
34
9
XMA22
NOMESCO Finland
General examination of pregnant woman
3.5
27.0
140
462
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.8
26.2
202
874
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
+∞
26.2
25
*
WX230
NOMESCO Finland
Plexus blockade of nervus pudendus
8.7
26.1
57
70
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
35.9
24.4
31
9
SPAT1272
SPAT
Drug screening
32.3
23.9
31
10
J05AB01
ATC
aciclovir; systemic
2.5
23.7
229
1119
WX307
NOMESCO Finland
Obstetric epidural analgesia
2.8
23.0
166
684
WX234
NOMESCO Finland
Paracervical blockade
4.7
22.7
80
185
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
6.3
22.4
61
104
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.6
22.3
186
834
ZXD05
NOMESCO Finland
Urgent procedure
2.2
22.0
302
1744
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
40.0
21.8
27
7
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
51.6
21.2
25
5
WX740
NOMESCO Finland
Nitrogen oxide therapy
22.3
21.0
30
14
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
2.4
20.0
212
1073
Z22.5
ICD-10 Finland
Carrier of viral hepatitis
75.6
19.8
22
*
Z39.2
ICD-10 Finland
Routine postpartum follow-up
2.2
18.9
241
1322
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
39.5
18.6
23
6
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
18.1
18.4
28
16
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
20.0
18.3
27
14
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.5
18.3
162
741
O98.0
ICD-10 Finland
Tuberculosis complicating pregnancy, childbirth and the puerperium
+∞
17.8
17
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
32.3
17.1
22
7
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
92.2
16.6
18
*
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
2.6
16.2
127
541
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
19.0
16.1
24
13
Z2446
NOMESCO Finland
Social worker
3.7
15.8
70
201
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
2.0
15.8
251
1496
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
+∞
15.7
15
*
W78
ICPC
Pregnancy
2.0
15.6
247
1466
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
86.9
15.6
17
*
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
86.9
15.6
17
*
P01AB01
ATC
metronidazole; oral, rectal
1.9
15.5
351
2379
W84
ICPC
Pregnancy high risk
3.4
14.9
75
238
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
18.8
14.8
22
12
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
21.6
14.7
21
10
Z2221
NOMESCO Finland
Medical doctor
2.0
14.7
246
1487
6479X
ICD-9 Finland
Infective and parasitic conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Unspecified infection or infestation
+∞
14.6
14
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
36.8
14.5
18
5
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
5.3
14.5
44
87
SPAT1379
SPAT
Health check-up of pregnant person
2.1
14.2
189
1035
R3110
NOMESCO Finland
Psychosocial training
12.3
14.2
25
21
ZXE00
NOMESCO Finland
One hour or less
1.9
14.0
321
2158
N06AB04
ATC
citalopram; systemic
2.1
13.5
186
1035
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.4
13.3
65
202
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
40.9
13.2
16
*
SPAT1265
SPAT
Breathalyser
12.4
13.2
23
19
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
11.2
13.1
24
22
A60.9
ICD-10 Finland
Anogenital herpesviral infection, unspecified
19.5
13.0
19
10
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.2
12.8
144
732
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.7
12.4
55
159
SPAT1197
SPAT
Extensive health check-up of expecting family
1.9
12.2
214
1295
LCH11
NOMESCO Finland
Pharmacologic abortion
2.7
12.2
87
350
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
2.1
12.1
144
749
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
12.1
304
2082
8811
FHL
Cesarean section
2.8
11.8
79
304
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
3.2
11.7
63
211
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
11.6
401
3010
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
10.3
11.6
22
22
6472X
ICD-9 Finland
Infective and parasitic conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other venereal diseases
+∞
11.5
11
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.4
11.2
55
172
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
11.4
11.1
20
18
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
11.1
65
232
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
11.0
576
4864
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
44.0
10.9
13
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
18.1
10.8
16
9
Z3232
NOMESCO Finland
Midwife
2.0
10.8
149
823
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
16.3
10.4
16
10
Z37.0
ICD-10 Finland
Single live birth
1.9
10.4
160
920
B17.1
ICD-10 Finland
Acute hepatitis C
33.0
10.4
13
*
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
1.9
10.1
161
933
N05BA04
ATC
oxazepam; oral
1.8
10.1
194
1203
SPAT1254
SPAT
Administration of medicine
2.4
10.0
87
387
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.9
9.7
153
882
N05AH04
ATC
quetiapine; oral
1.9
9.7
153
885
MAX99
NOMESCO Finland
Assistance to normal delivery
1.9
9.6
156
909
SGA01
NOMESCO Finland
Tooth opening as first aid
1.9
9.6
154
894
N07BB01
ATC
disulfiram; oral
4.1
9.5
36
91
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
3.0
9.5
55
194
R74
ICPC
Upper respiratory infection acute
1.7
9.5
309
2234
D72
ICPC
Viral hepatitis
101.3
9.4
10
*
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
101.3
9.4
10
*
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
30.4
9.4
12
*
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
9.4
9
*
339
Kela drug reimbursment
Product containing buprenorfine and naloxone
+∞
9.4
9
*
Z30.2
ICD-10 Finland
Sterilization
2.0
9.3
131
726
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
9.2
237
1603
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
3.0
9.1
52
181
J05AB11
ATC
valaciclovir; oral
2.1
9.1
111
579
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
9.1
427
3386
SPAT1227
SPAT
Substance abuse rehabilitation
15.8
9.1
14
9
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
15.8
9.1
14
9
6440A
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]
4.1
9.0
34
86
N03AX16
ATC
pregabalin; oral
1.9
9.0
151
888
SPAT1380
SPAT
Postpartum check-up
1.9
9.0
146
851
Z29
ICPC
Social problem NOS
4.7
9.0
29
63
WX290
NOMESCO Finland
Other blockade of nerve
1.6
9.0
409
3217
A02BC01
ATC
omeprazole; systemic
1.8
9.0
162
978
O80.8
ICD-10 Finland
Other single spontaneous delivery
2.4
8.8
75
332
N03AE01
ATC
clonazepam; systemic
3.3
8.8
44
141
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
8.8
129
723
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
2.8
8.8
56
212
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
50.6
8.7
10
*
N05BA01
ATC
diazepam; systemic, rectal
2.2
8.6
86
411
RS120
NOMESCO Finland
NA
27.9
8.5
11
*
RS310
NOMESCO Finland
NA
27.9
8.5
11
*
O35.4
ICD-10 Finland
Maternal care for (suspected) damage to fetus from alcohol
27.9
8.5
11
*
AA1AD
NOMESCO Finland
CT of head and brain
2.0
8.3
103
542
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
3.3
8.3
41
131
K02.1
ICD-10 Finland
Caries of dentine
1.6
8.3
470
3871
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
11.9
8.1
14
12
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
8.1
417
3346
K04.08
ICD-10 Finland
Other specified pulpit
2.3
8.0
77
361
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
2.7
8.0
54
210
M01AE01
ATC
ibuprofen; systemic, rectal
2.2
8.0
694
6428
N06AB10
ATC
escitalopram; oral
1.7
8.0
195
1292
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
7.9
104
561
Z3231
NOMESCO Finland
Registered nurse
1.7
7.8
172
1103
R42
ICD-10 Finland
Dizziness and giddiness
1.9
7.8
121
693
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
7.7
330
2519
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.7
202
1361
N06AX16
ATC
venlafaxine; oral
1.8
7.6
135
807
O04.1
ICD-10 Finland
Medical abortion, incomplete, complicated by delayed or excessive haemorrhage
5.5
7.6
21
39
A05AA02
ATC
ursodeoxycholic acid; oral
4.2
7.6
27
66
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
7.4
71
333
IFC01
NOMESCO Finland
Withdrawal and replacement therapy for opioid addiction
80.9
7.4
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
7.4
136
824
N07BC51
ATC
buprenorphine, combinations; sublingual
+∞
7.3
7
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
7.3
7
*
O98.1
ICD-10 Finland
Syphilis complicating pregnancy, childbirth and the puerperium
+∞
7.3
7
*
XLA10
NOMESCO Finland
NA
2.4
7.3
62
274
S06.0
ICD-10 Finland
Concussion
2.2
7.3
72
343
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
7.2
257
1874
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
30.3
7.2
9
*
RS312
NOMESCO Finland
NA
30.3
7.2
9
*
D11
ICPC
Diarrhoea
1.9
7.1
109
618
EBA30
NOMESCO Finland
Excision of root of tooth
3.7
7.1
29
80
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.1
467
3907
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.3
7.1
33
102
D10
ICPC
Vomiting
2.1
7.1
78
392
W85
ICPC
Gestational diabetes
2.3
7.0
63
285
R53
ICD-10 Finland
Malaise and fatigue
1.7
7.0
147
925
K04.0
ICD-10 Finland
Pulpitis
1.9
7.0
101
563
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.9
602
5364
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
2.3
6.9
60
269
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.4
6.9
31
93
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
13.9
6.9
11
8
P18
ICPC
Medication abuse
8.4
6.8
14
17
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
2.0
6.8
86
453
MAA00
NOMESCO Finland
Amniocentesis
2.9
6.8
39
138
6412B
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Premature separation of placenta[ABLATIO PLACENTAE ANTETEMPUS,SYNN PÄÄTT HOITOJAKSO]
40.4
6.8
8
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.8
6.8
21
45
-1
NOMESCO Finland
NA
1.5
6.8
280
2104
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
2.2
6.7
68
327
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.1
6.7
73
366
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
12.4
6.6
11
9
Z36.9
ICD-10 Finland
Antenatal screening, unspecified
3.4
6.5
30
92
R50.9
ICD-10 Finland
Fever, unspecified
1.9
6.5
92
509
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.9
6.5
90
495
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
2.5
6.5
49
206
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
6.4
79
413
SPAT1196
SPAT
Monitoring of normal pregnancy
1.8
6.4
113
675
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
6.3
233
1698
W01
ICPC
Question of pregnancy
4.6
6.3
20
44
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
3.1
6.3
32
106
N05BA12
ATC
alprazolam; oral
2.0
6.3
76
395
G02CB01
ATC
bromocriptine; systemic
3.2
6.3
31
101
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
26.9
6.2
8
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
6.2
117
714
R2110
NOMESCO Finland
Giving the first information
2.1
6.2
70
356
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
2.2
6.2
60
283
A02BC02
ATC
pantoprazole; systemic
1.5
6.1
401
3300
N01
ICPC
Headache
1.8
6.1
106
627
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
6.1
81
438
N77.1*A60.0
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
61
44
14.92
67.09
2.2
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
32
5
66.52
28.12
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
75
203
3.97
24.76
9.5
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
101
335
3.30
24.60
17.5
2.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
27
27
10.31
23.93
2.6
3.0
%
33.3
52.1
—
10
11
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
353
2203
2.07
21.93
3.6
2.8
u/l
29.9
27.2
1.25
339
2109
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
326
2008
2.05
20.69
2.0
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
330
2067
2.01
19.77
3.5
3.9
g/l
37.4
37.2
0.34
307
1937
(3034274) Bile acid [Moles/volume] in Serum --fasting
63
180
3.71
19.22
2.6
2.3
umol/l
4.6
4.8
0.09
51
131
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
412
2823
1.94
18.67
5.5
5.1
umol/l
9.4
9.5
0.10
387
2663
(3027944) Amphetamines [Presence] in Urine
114
471
2.65
18.55
8.5
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
107
435
2.68
17.96
9.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
113
475
2.60
17.73
9.2
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
113
478
2.59
17.50
9.6
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
96
375
2.77
17.39
10.2
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
112
475
2.58
17.24
9.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
313
2016
1.90
16.56
3.3
2.9
e6/l
51.6
54.7
0.06
195
1265
(3033658) Prothrombin time (PT) actual/Normal
234
1368
2.00
16.48
3.1
3.0
%
97.9
99.9
0.79
225
1320
(3002582) Erythrocytes [#/volume] in Urine
253
1526
1.96
16.25
2.7
2.6
e6/l
204.8
166.9
0.07
181
1136
(3042517) Benzodiazepines panel - Urine
20
6
34.12
15.79
6.0
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
572
4499
1.93
15.78
6.8
6.2
u/l
71.5
72.3
0.19
541
4244
(3021589) Normoblasts [#/volume] in Blood
402
2846
1.82
15.41
8.8
7.2
e9/l
0.0
0.0
0.52
328
2352
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
39
92
4.40
15.41
2.9
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
358
2453
1.83
15.23
2.3
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
298
1932
1.86
15.14
6.0
5.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
104
456
2.47
14.86
2.8
2.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
49
141
3.64
14.79
4.9
3.2
g/l
0.1
0.4
1.19
33
48
(3030467) Casts [#/volume] in Urine by Automated count
228
1372
1.92
14.49
2.8
2.5
e6/l
0.2
0.3
1.39
164
996
(40761536) Microorganisms panel - Urine sediment
122
582
2.29
14.40
3.4
2.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
200
1156
1.97
14.29
2.0
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
108
494
2.37
14.03
6.2
4.7
mmol/l
1.0
1.0
0.41
103
463
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
111
514
2.34
14.03
2.6
2.2
u/l
31.6
41.6
0.98
96
425
(36304419) Bacteria [Presence] in Urine
228
1389
1.89
13.87
2.7
2.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
15
14
10.90
13.78
1.7
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
98
452
2.33
12.46
1.5
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
256
1663
1.79
12.44
2.6
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
273
1815
1.76
12.21
3.2
2.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
418
3139
1.69
11.88
4.3
3.7
mmol/l
6.0
6.2
1.16
388
2815
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
167
964
1.92
11.75
2.0
1.6
%
1.4
1.3
1.76
144
870
(3000850) Epithelial cells [#/volume] in Urine
177
1046
1.89
11.58
2.2
2.2
e6/l
10.0
9.4
0.13
161
918
(4198724)
21
37
5.80
11.52
4.9
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
539
4371
1.70
11.11
4.6
3.5
e6/l
79.5
832.5
—
8
42
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
258
1728
1.72
11.03
2.3
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
92
436
2.25
10.95
1.8
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
431
3307
1.65
10.92
3.5
2.9
estimate
0.0
0.0
0.50
112
622
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
81
365
2.36
10.84
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
251
1678
1.72
10.76
1.9
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
430
3306
1.64
10.74
4.8
4.1
estimate
0.0
0.0
0.38
112
651
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
140
3.11
10.10
1.8
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
430
3343
1.61
9.98
3.6
3.0
estimate
0.0
0.0
1.06
114
630
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
27
68
4.07
9.84
6.6
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
164
995
1.81
9.73
5.2
3.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
84
3.67
9.46
2.3
2.1
mmol/l
2.0
2.1
0.13
17
52
(3037467) Urinalysis macro (dipstick) panel - Urine
553
4606
1.64
9.38
4.4
3.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
34
106
3.30
9.13
1.1
1.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
379
2901
1.58
9.09
6.8
5.3
%
0.7
0.7
0.40
353
2712
(3013115) Eosinophils [#/volume] in Blood
427
3363
1.57
9.02
6.7
5.6
e9/l
0.2
0.2
0.11
387
3043
(3043410) Blood group antigens tested for on Red Blood Cells
13
18
7.32
8.86
1.2
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
748
6844
2.27
8.74
11.8
9.3
mg/l
19.2
17.9
0.50
599
5148
(40758558) Short blood count panel - Blood
227
1560
1.63
8.43
7.2
6.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
389
3033
1.55
8.37
6.6
5.2
%
2.6
2.7
0.10
361
2831
(3026782) Osmolality of Urine
154
958
1.75
8.30
2.5
2.3
mosm/kgh2o
511.2
526.0
0.37
136
819
(3021879) Hepatitis B virus core Ab [Presence] in Serum
125
732
1.84
8.24
2.1
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
80
403
2.09
8.16
1.6
2.3
g/l
0.2
0.2
0.00
71
385
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
133
797
1.80
8.13
2.3
2.1
u/l
8185.7
4775.6
0.58
49
324
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
193
1284
1.66
8.11
2.2
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
390
3058
1.53
8.08
6.9
5.4
%
7.5
7.7
0.78
368
2887
(3009508) Creatinine [Moles/volume] in Urine
197
1322
1.65
7.99
6.4
3.1
mmol/l
7.4
7.8
0.49
166
1167
(3001604) Monocytes [#/volume] in Blood
407
3226
1.53
7.98
6.7
5.3
e9/l
0.5
0.5
0.42
356
2877
(3006315) Basophils [#/volume] in Blood
408
3237
1.53
7.96
6.7
5.3
e9/l
0.0
0.0
0.15
356
2874
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
105
3.13
7.93
1.1
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
54
236
2.38
7.76
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
76
3.50
7.72
1.7
2.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
402
3196
1.51
7.66
6.7
5.2
%
31.1
30.0
1.35
378
3015
(3007853) Bacteria identified in Skin by Aerobe culture
114
666
1.83
7.55
1.8
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
765
7130
2.40
7.43
10.1
7.8
u/l
25.5
23.5
3.30
751
6951
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
265
1942
1.54
7.31
2.6
2.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
39
150
2.68
7.30
1.6
1.6
mmol/l
7.9
7.6
0.18
16
82
(3010421) pH of Blood
30
100
3.08
7.26
2.3
2.6
ph
7.4
7.4
1.14
30
83
(3018010) Neutrophils/100 leukocytes in Blood
396
3168
1.49
7.14
6.6
5.0
%
55.2
56.3
1.32
371
2990
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
262
1929
1.53
7.02
1.8
1.7
pmol/l
105.1
98.9
0.84
123
1092
(3002385) Erythrocyte distribution width [Ratio]
675
6065
1.69
7.02
14.3
11.0
%
13.4
13.4
0.36
663
5947
(3013650) Neutrophils [#/volume] in Blood by Automated count
447
3672
1.49
7.02
9.1
8.1
e9/l
3.8
3.9
0.50
392
3256
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
279
2083
1.52
7.00
5.0
4.6
mmol/l
1.2
1.2
0.24
265
1915
(3029937) Albumin [Presence] in Urine by Test strip
238
1726
1.54
6.80
3.8
3.2
estimate
0.0
0.0
0.28
116
644
(3019198) Lymphocytes [#/volume] in Blood
414
3369
1.47
6.69
6.6
5.3
e9/l
2.1
2.0
0.30
369
3064
(3018418) pH of Serum or Plasma
198
1392
1.56
6.47
3.3
3.3
ph
7.4
7.4
0.08
52
278
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
212
1516
1.54
6.41
1.9
1.7
mg/l
0.7
0.7
0.06
158
1127
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
155
1040
1.61
6.15
1.6
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
573
5012
1.49
6.13
3.6
2.7
u/l
38.8
31.7
1.33
547
4844
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
177
2.39
6.09
1.9
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
78
3.14
6.08
2.1
1.7
%
18.1
16.9
—
9
34
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
44
197
2.30
6.03
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
57
284
2.08
6.02
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
164
1121
1.58
6.01
1.4
1.4
titre
491.9
544.1
0.11
37
234
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
122
777
1.67
5.95
2.6
2.2
e6/l
1.2
1.6
0.22
51
419
(3023103) Potassium [Moles/volume] in Serum or Plasma
704
6464
1.70
5.92
10.7
8.6
mmol/l
3.9
3.9
0.36
687
6263
(3032080) INR in Blood by Coagulation assay
217
1585
1.50
5.88
3.8
4.6
inr
1.1
1.0
0.22
89
564
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
288
2226
1.46
5.87
1.9
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
702
6449
1.68
5.79
10.6
8.5
mmol/l
139.4
139.6
1.62
686
6266
(3012095) Magnesium [Moles/volume] in Serum or Plasma
113
711
1.69
5.76
3.2
3.3
mmol/l
0.8
0.8
0.75
100
675
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
305
2391
1.44
5.73
5.4
5.1
mmol/l
1.2
1.2
0.02
254
1997
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
115
728
1.68
5.73
2.6
2.3
e6/l
4.2
4.7
0.16
43
372
(3027945) Reticulocytes/100 erythrocytes in Blood
64
339
1.96
5.72
1.8
2.2
%
1.6
1.7
0.22
56
305
(3044889) 12 lead EKG panel
456
3852
1.42
5.62
2.7
2.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
19
56
3.45
5.61
2.1
1.4
mmol/l
1.7
1.6
0.38
19
56
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
33
4.30
5.57
2.9
2.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
750
7039
1.93
5.50
12.0
9.5
umol/l
63.4
65.4
5.23
750
7034
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
116
744
1.65
5.50
2.9
2.7
ng/l
62.5
354.0
1.27
40
331
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
107
672
1.68
5.49
1.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
110
701
1.66
5.34
1.8
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
199
1453
1.49
5.34
2.1
2.0
mg/l
2.6
2.6
0.10
171
1261
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
196
1430
1.49
5.27
1.3
1.3
iu/ml
25.3
26.1
0.05
65
475
(3025130) Human papilloma virus identified in Specimen
48
236
2.10
5.27
1.9
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
87
524
1.74
5.20
1.6
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
672
6151
1.55
5.14
9.9
7.6
ml/min/173m2
97.0
93.6
4.90
570
4961
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
56
296
1.96
5.06
1.5
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
460
3934
1.39
5.03
3.2
2.7
ug/l
58.4
60.2
0.21
431
3744
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
122
810
1.60
5.02
2.5
2.2
mmol/l
2.4
2.4
0.87
93
711
(3013707) Erythrocyte sedimentation rate by Westergren method
544
4797
1.41
4.91
3.9
3.5
mm/h
10.2
8.9
1.91
513
4538
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
145
1010
1.53
4.84
2.0
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
187
1376
1.47
4.78
2.3
2.0
u/l
124.2
122.8
0.03
175
1312
(3022806) Fractional oxyhemoglobin in Capillary blood
17
52
3.32
4.77
2.2
1.5
%
89.9
91.6
0.88
17
52
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
325
2641
1.39
4.76
3.6
2.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
186
1370
1.46
4.72
1.3
1.3
u/ml
6.8
10.2
0.48
78
613
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
71
415
1.78
4.71
1.8
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
21
74
2.89
4.68
1.0
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
5
14.10
4.58
2.0
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
90
568
1.66
4.54
2.0
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
254
1997
1.40
4.47
3.0
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
55
302
1.88
4.46
1.9
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
198
1492
1.43
4.43
1.5
1.6
mmol/l
1.3
1.3
0.05
171
1335
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
98
637
1.61
4.40
2.4
2.2
umol/l
4.4
4.7
0.28
80
528
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
227
1756
1.41
4.38
2.4
2.3
u/l
54.9
56.3
0.27
206
1647
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
35
3.76
4.38
2.8
2.6
%
10.4
13.8
—
7
18
(3011397) Hemoglobin [Presence] in Urine by Test strip
190
1425
1.44
4.36
3.8
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
71
426
1.73
4.32
1.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
607
5511
1.41
4.22
4.2
3.8
mmol/mol
36.5
37.2
1.12
572
5278
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
32
147
2.23
4.20
1.4
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
100
661
1.59
4.20
1.6
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
145
1041
1.48
4.16
1.4
1.4
nmol/l
19.4
20.1
0.32
128
946
(3003694) ABO and Rh group [Type] in Blood
291
2367
1.36
4.09
2.1
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
59
342
1.78
4.05
1.4
1.8
g/l
1.4
1.4
0.07
53
320
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
669
6202
1.46
3.97
3.8
3.3
mmol/l
5.5
5.5
0.01
625
5900
(3015377) Calcium [Moles/volume] in Serum or Plasma
228
1791
1.38
3.97
3.1
3.1
mmol/l
2.4
2.3
1.57
197
1644
(3019150) Specific gravity of Urine by Refractometry
185
1414
1.40
3.77
5.7
3.1
kg/l
1.0
1.0
0.53
17
208
(3007164) IgA [Mass/volume] in Serum or Plasma
207
1616
1.38
3.71
1.4
1.4
g/l
2.1
2.1
0.01
125
1076
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
373
3185
1.32
3.66
4.5
3.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
32
156
2.09
3.66
2.0
2.9
%
1.7
1.3
0.86
32
156
(3014576) Chloride [Moles/volume] in Serum or Plasma
69
431
1.66
3.65
6.2
6.8
mmol/l
104.4
105.0
0.31
69
426
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
30
3.70
3.65
1.7
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
142
1043
1.44
3.61
2.1
2.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
97
660
1.53
3.60
2.1
2.0
nmol/l
375.7
378.0
0.05
92
619
(3019230) Fractional oxyhemoglobin in Venous blood
15
51
2.98
3.59
1.7
1.8
%
57.3
63.2
0.38
15
51
(3000991) Gas panel - Venous blood
47
265
1.82
3.56
6.7
8.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
40
214
1.91
3.55
2.1
2.5
e9/l
66.8
74.0
0.78
29
158
(40768797) Stomach Pathology biopsy report
114
806
1.48
3.53
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
125
2.20
3.51
1.2
1.3
—
—
—
0
0
(3012544) pH of Venous blood
53
313
1.74
3.45
1.9
2.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
59
2.75
3.34
1.3
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
698
6577
1.45
3.28
5.4
4.8
mu/l
1.6
1.9
0.72
664
6323
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
320
2712
1.30
3.20
2.4
2.2
nmol/l
73.1
74.2
0.31
295
2555
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
100
703
1.48
3.19
2.1
2.6
ng/l
398.3
389.3
0.02
76
564
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
285
2382
1.30
3.15
1.6
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
96
674
1.48
3.08
1.9
1.5
nmol/l
1276.9
1149.7
0.73
78
535
(3002032) Base excess in Venous blood by calculation
50
301
1.70
3.07
1.8
3.1
mmol/l
2.1
1.9
0.16
39
241
(3023183) Ammonium ion [Moles/volume] in Plasma
18
74
2.47
3.06
2.4
2.6
umol/l
51.0
31.8
0.57
12
66
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
627
5825
1.34
3.03
4.8
4.2
pmol/l
14.3
14.2
0.50
590
5531
(4306422)
26
127
2.08
3.00
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
51
2.78
2.99
1.4
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
673
6329
1.38
2.94
4.5
3.8
—
—
—
0
0
(3036489) Thrombin time
41
237
1.77
2.90
1.7
2.0
s
20.5
20.5
0.03
31
193
(3014111) Lactate [Moles/volume] in Serum or Plasma
51
314
1.67
2.89
6.4
6.8
mmol/l
1.2
1.2
0.05
51
299
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
47
2.79
2.82
1.5
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
201
1626
1.31
2.78
2.9
2.4
ng/l
25.0
19.8
0.15
79
612
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
596
1.48
2.76
1.8
2.2
%
22.8
24.6
0.58
72
516
(3005719) IgG [Mass/volume] in Serum or Plasma
68
456
1.54
2.73
2.1
2.5
g/l
11.1
10.4
0.97
61
423
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
48
2.74
2.73
1.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
24
119
2.05
2.68
1.1
1.3
u/ml
92.4
109.5
—
7
25
(3011648) Oxygen content in Venous blood
9
24
3.78
2.67
2.1
2.3
%
10.7
11.2
—
9
24
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
137
1053
1.36
2.67
1.5
1.5
pmol/l
432.6
21458758.7
1.05
115
960
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
49
2.68
2.63
1.4
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
82
577
1.47
2.63
1.5
1.5
mu/l
276.0
303.5
0.52
70
519
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
15
4.70
2.60
1.6
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
25
3.63
2.58
1.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
67
454
1.52
2.58
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
67
455
1.52
2.55
1.6
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
11
5.49
2.54
4.7
3.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
27
143
1.92
2.53
1.2
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
143
1.92
2.53
1.7
1.5
mmol/l
5.9
6.9
—
9
100
(40761511) CBC panel - Blood by Automated count
760
7348
1.59
2.49
10.8
8.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
109
2.05
2.48
3.7
3.8
e9/l
3.4
4.2
1.67
22
109
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
273
1.65
2.46
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
25
131
1.94
2.43
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
27
3.36
2.39
1.1
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
111
2.01
2.37
4.3
4.1
%
51.9
56.8
1.85
22
111
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
147
1.87
2.35
1.3
1.3
u/ml
227.7
248.5
0.23
22
98
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
155
1.84
2.32
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
210
1749
1.27
2.29
4.1
3.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
53
2.48
2.28
1.4
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
13
53
2.48
2.28
1.0
1.1
iu/ml
13.1
6.6
—
5
19
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
156
1.82
2.28
1.3
1.4
e6/l
22.7
6.6
0.41
19
128
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
156
1.82
2.28
1.5
1.5
e6/l
14.6
123.6
1.90
20
134
(3044640) Blood type and Crossmatch panel - Blood
235
1986
1.26
2.26
2.0
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
114
1.96
2.22
2.8
1.9
g/l
2.6
3.1
1.59
17
89
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
19
3.71
2.15
1.4
3.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
102
775
1.36
2.15
1.8
2.1
umol/l
13.8
15.0
0.91
91
720
(3022217) INR in Platelet poor plasma by Coagulation assay
56
382
1.50
2.12
3.5
10.3
inr
1.0
1.1
1.65
16
72
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
28
160
1.78
2.12
1.2
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
67
476
1.44
2.08
1.7
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
31
2.92
2.07
2.6
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
69
2.20
2.05
1.2
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
69
2.20
2.05
1.8
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
118
1.89
2.03
2.8
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
118
1.89
2.03
2.8
1.9
g/l
3.2
3.9
2.48
17
87
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
118
1.89
2.03
2.8
1.9
g/l
6.6
7.4
2.03
17
95
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
103
793
1.34
2.00
1.3
1.2
iu/ml
175.4
161.1
0.14
50
327
(3052851) Hemolysis interference index of Serum or Plasma
24
134
1.82
1.97
2.0
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
705
6768
1.33
1.96
12.9
9.9
%
39.5
39.7
0.44
584
5757
(3024731) MCV [Entitic volume]
794
7802
2.10
1.96
18.2
13.8
fl
90.2
90.0
0.38
789
7733
(3035941) MCH [Entitic mass]
794
7803
2.09
1.94
18.2
13.8
pg
30.1
30.0
0.89
789
7732
(3016228) CD19 cells/100 cells in Blood
6
16
3.77
1.93
5.0
3.0
%
8.3
5.1
—
6
16
(21494814) CD8 cells/100 lymphocytes in Specimen
6
16
3.77
1.93
4.7
2.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
71
2.13
1.93
1.9
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
226
1934
1.23
1.91
1.3
1.3
u/ml
0.6
1.5
2.10
76
556
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
158
1.73
1.91
10.1
10.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
794
7805
2.07
1.90
18.2
13.9
e12/l
4.4
4.5
4.13
779
7666
(3010813) Leukocytes [#/volume] in Blood
794
7806
2.07
1.88
18.3
13.9
e9/l
6.9
6.7
0.64
782
7651
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
22
3.20
1.88
1.0
1.0
—
—
—
0
0
(3013512) EKG study
149
1218
1.27
1.88
2.7
2.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
8
28
2.88
1.86
4.5
3.3
e9/l
0.2
0.2
—
8
28
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
81
609
1.37
1.85
1.6
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
793
7795
2.00
1.84
18.4
13.9
e9/l
264.9
271.0
2.10
781
7655
(36660697) Celiac disease serology panel - Serum
86
655
1.35
1.81
1.2
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
794
7812
2.02
1.77
18.4
13.9
g/l
132.1
133.6
3.30
789
7743
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
102
1.88
1.77
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
88
1.95
1.76
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
132
1.76
1.75
1.1
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
9
36
2.52
1.74
3.9
2.2
—
3.8
—
0
6
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
30
2.68
1.72
1.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
75
564
1.36
1.72
1.5
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
11
48
2.31
1.71
3.4
3.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
591
1.35
1.71
2.6
3.4
pmol/l
4.5
4.6
0.08
71
526
(3003396) Base excess in Arterial blood by calculation
51
359
1.45
1.70
9.0
7.6
mmol/l
1.1
1.0
0.12
40
256
(3004588) Protein electrophoresis panel - Serum or Plasma
31
197
1.60
1.65
2.9
2.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
14
3.59
1.61
1.0
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
19
106
1.81
1.60
1.2
1.1
iu/ml
1.1
4372.2
—
7
29
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
74
564
1.34
1.57
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
42
290
1.47
1.56
1.6
1.9
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
74
565
1.34
1.56
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
74
565
1.34
1.56
1.5
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
51
2.17
1.51
1.2
1.3
—
58.3
—
0
6
(3021901) Oxygen saturation in Capillary blood
11
51
2.17
1.51
1.5
2.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
15
79
1.92
1.50
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
65
490
1.36
1.49
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
683
6583
1.24
1.45
3.9
3.4
mmol/l
2.9
2.9
0.35
645
6298
(3004789) Transferrin [Mass/volume] in Serum or Plasma
87
688
1.30
1.45
1.8
2.1
g/l
2.5
2.5
0.06
80
643
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
16
3.14
1.44
1.0
1.1
mg/g
5.4
5.9
—
5
16
(3035637) Corticotropin [Mass/volume] in Plasma
13
66
1.99
1.44
1.2
1.7
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
22
2.74
1.43
2.0
1.9
ug/l
13.6
30.5
—
6
22
(3051651) Icteric interference index of Serum or Plasma
6
22
2.74
1.43
1.8
3.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
322
2923
1.17
1.37
2.0
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
224
1.49
1.35
1.4
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
266
1.45
1.34
1.5
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
90
1.79
1.33
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
61
1.98
1.33
1.3
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
83
1.82
1.32
1.5
2.7
mmol/l
23.1
24.6
1.46
15
75
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
83
1.82
1.32
1.2
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
46
620
0.73
1.31
3.4
3.1
%
35.1
32.6
1.01
35
487
(3051611) Lipemic interference index of Serum or Plasma
8
34
2.37
1.29
1.9
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
58
441
1.34
1.29
1.2
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
677
6539
1.22
1.28
3.7
3.3
mmol/l
4.8
4.9
0.46
648
6295
(40760888) Immunoglobulin light chains.free panel - Serum
10
48
2.10
1.28
5.7
2.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
99
1.73
1.28
2.5
2.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
130
1.63
1.27
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
168
1452
1.20
1.27
1.8
1.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
35
2.30
1.27
1.1
1.8
pg
29.9
31.8
—
8
35
(3006653) Thiamine [Moles/volume] in Blood
6
25
2.41
1.24
1.0
1.9
nmol/l
121.3
141.2
—
6
25
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
45
2.01
1.23
1.3
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
116
1.65
1.22
2.2
3.2
mg/l
0.9
1.3
4.18
19
108
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
19
2.64
1.21
2.4
2.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
37
2.17
1.21
1.0
1.2
miu/ml
1341.7
1650.7
—
8
37
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
37
2.17
1.21
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
674
6516
1.21
1.21
3.6
3.2
mmol/l
1.5
1.6
2.52
642
6254
(3008898) HLA-B27 [Presence]
57
438
1.32
1.19
1.1
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
6
26
2.32
1.19
1.0
1.2
u/l
22.0
20.9
—
6
20
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
6
26
2.32
1.19
1.0
1.2
u/l
105.1
90.9
—
6
21
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
126
1.60
1.15
1.4
1.2
u/ml
2.1
5.8
—
8
44
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
41
549
0.73
1.14
1.5
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
201
1.46
1.11
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
38
278
1.39
1.09
1.9
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
61
480
1.29
1.09
1.3
1.3
miu/ml
183.6
230.2
0.60
26
251
(3048689) Calprotectin [Mass/mass] in Stool
123
1051
1.20
1.07
2.0
2.2
ug/g
85.9
86.1
0.00
98
809
(3002256) Pathology report gross observation
103
866
1.22
1.06
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
33
2.13
1.05
3.7
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
106
1.62
1.03
1.5
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
34
2.07
1.03
1.1
2.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
47
1.93
1.02
1.1
1.3
—
—
—
0
0
(4024509)
9
47
1.93
1.02
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
205
1.43
1.02
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
115
1.58
1.00
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
115
1.58
1.00
2.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
85
706
1.23
0.99
1.4
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
70
569
1.25
0.99
2.2
2.2
au/ml
18.9
20.5
—
6
45
(3051387) C reactive protein [Mass/volume] in Capillary blood
18
116
1.56
0.97
2.1
3.2
mg/l
18.5
23.3
—
9
77
(1002224) Polysomnography panel
46
355
1.31
0.97
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
50
1.81
0.97
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
62
1.78
0.94
1.6
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
62
1.78
0.94
1.6
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
357
1.31
0.94
3.9
4.0
ug/l
2.8
109.3
0.54
35
258
(3023323) Follitropin [Units/volume] in Serum or Plasma
101
860
1.20
0.93
1.3
1.3
iu/l
25.8
26.3
0.05
79
734
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
201
1.41
0.92
1.1
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
28
2.15
0.91
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
63
1.76
0.90
1.6
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
63
1.76
0.90
1.6
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
63
1.76
0.90
1.6
1.2
—
—
—
0
0
(4034850)
28
203
1.39
0.88
9.4
6.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
72
1.68
0.85
1.4
1.2
u/ml
0.1
0.5
—
5
23
(3026493) Urate [Moles/volume] in Serum or Plasma
150
1331
1.16
0.85
1.6
2.0
umol/l
2389.1
3190.5
0.14
139
1209
(3035320) C reactive protein [Mass/volume] in Body fluid
8
47
1.71
0.81
1.4
1.4
—
—
—
0
0
(3020891) Body temperature
19
132
1.45
0.76
5.5
5.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
34
1.77
0.76
1.0
1.1
u/l
196.0
637.4
—
6
28
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
84
1.56
0.72
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
12
182
0.65
0.71
1.0
1.0
u/ml
1.4
2.1
—
7
98
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
26
1.93
0.70
1.2
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
230
1.32
0.70
1.7
1.6
iu/ml
1.7
0.3
—
6
41
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
239
0.71
0.69
1.0
1.1
u/ml
0.9
4.2
—
8
129
(3012516) Albumin [Mass/volume] in Urine
117
1037
1.15
0.69
2.6
3.3
mg/l
25.6
576.0
2.49
79
645
(3000492) Spirometry study
80
688
1.18
0.69
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
121
1076
1.15
0.68
3.2
4.0
mg/mmol
4.4
10.7
1.57
83
670
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
69
1.60
0.68
1.2
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
104
1176
0.87
0.67
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
86
1.52
0.66
1.2
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
44
1.60
0.65
1.6
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
25
190
1.33
0.63
7.8
4.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
63
1.59
0.62
1.7
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
130
1.39
0.61
1.5
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
30
1.67
0.61
1.8
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
139
0.64
0.61
1.4
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
64
1.57
0.58
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
64
1.57
0.58
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
64
1.57
0.58
1.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
3.0
—
70.2
—
0
13
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
6
35
1.72
0.57
1.7
2.0
mg/l
11.1
8.5
—
6
30
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
218
0.73
0.57
1.0
1.1
u/ml
0.9
0.9
—
6
95
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.55
0.55
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.55
0.55
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.55
0.55
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
72
629
1.16
0.54
1.4
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
5.7
3.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
45
378
1.20
0.53
4.3
3.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
91
1.44
0.53
1.3
1.9
—
—
—
0
0
(4027681)
10
66
1.52
0.52
1.2
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
50
425
1.19
0.52
3.5
3.8
%
0.6
0.7
0.11
13
77
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
63
1.43
0.52
1.4
1.4
g/l
0.8
0.9
—
9
63
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
169
0.71
0.52
1.5
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
290
1.22
0.48
1.3
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
46
1.53
0.48
5.7
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
46
1.53
0.48
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
46
1.53
0.48
1.1
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
49
420
1.18
0.48
3.5
4.2
%
0.1
1.1
0.50
13
76
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
10
143
0.70
0.48
3.3
2.9
mmol/l
25.0
24.4
—
10
133
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
61
693
0.87
0.45
1.5
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
24
192
1.26
0.45
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
24
192
1.26
0.45
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
330
1.19
0.44
1.7
1.7
—
—
—
0
0
(4268621)
12
86
1.40
0.44
2.7
2.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
51
443
1.16
0.43
3.4
4.1
%
0.1
0.1
0.16
15
94
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
31
1.62
0.43
1.6
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
158
1.27
0.42
1.3
1.3
ug/g
316.0
345.2
—
9
80
(3042733) HLA Ab [Presence] in Serum
0
15
0.00
0.41
0.0
3.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
34
1.47
0.40
1.0
1.1
iu/ml
205.5
152.9
—
5
34
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
60
1.34
0.40
1.3
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
53
466
1.15
0.40
3.4
4.0
%
0.6
0.9
0.77
16
107
(40768806) Pleura Pathology biopsy report
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(44813793)
9
66
1.37
0.38
1.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
66
1.37
0.38
1.6
1.2
nmol/l
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
36
1.39
0.38
2.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
98
1.33
0.37
1.5
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
216
1.21
0.37
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
235
1.20
0.36
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
71
783
0.90
0.35
1.6
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
134
0.74
0.35
1.5
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
227
1.20
0.35
2.5
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
45
1.34
0.34
1.3
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
253
0.83
0.33
1.0
1.1
u/ml
3.1
1.5
—
8
99
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
74
1.36
0.32
1.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
74
1.36
0.32
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
32
368
0.86
0.31
2.1
2.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
53
1.32
0.31
1.0
1.2
—
10.4
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
524
0.89
0.29
1.0
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
25
292
0.85
0.29
1.0
1.1
u/ml
4.1
3.5
—
5
46
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
56
1.25
0.29
1.6
1.2
u/l
12.5
12.2
—
7
47
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
184
0.81
0.29
1.1
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
416
0.88
0.27
1.7
1.7
mg/l
2.3
3.1
0.75
21
267
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
66
1.21
0.26
2.0
1.2
—
—
—
0
0
(4062490)
8
67
1.20
0.26
1.4
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
27
236
1.15
0.24
1.9
1.9
iu/l
3.8
4.9
—
8
101
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
78
1.29
0.24
3.8
2.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
38
1.32
0.23
4.4
2.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
2.2
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
24
274
0.87
0.23
1.1
1.5
pmol/l
57.3
100.0
0.55
24
266
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
11
88
1.25
0.22
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
25
219
1.15
0.22
2.2
2.9
ph
7.4
7.4
—
7
25
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
42
1.19
0.21
1.6
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
42.5
—
0
5
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
156
0.83
0.21
1.2
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
12
0.00
0.21
0.0
1.8
—
1.2
—
0
12
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
13
0.00
0.21
0.0
1.9
—
1.2
—
0
13
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
112
0.80
0.20
1.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
91
961
0.94
0.20
1.8
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
48
519
0.92
0.19
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
52
1.15
0.19
1.7
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
27
242
1.12
0.18
1.9
2.2
e6/l
0.3
0.1
0.31
27
229
(3022313) Gas panel - Capillary blood
13
153
0.85
0.18
2.7
3.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
55
513
1.08
0.18
2.2
2.2
e9/l
3.8
4.2
1.10
45
454
(4094501)
14
119
1.18
0.17
1.1
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
69
1.16
0.16
1.5
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
534
0.93
0.16
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
77
0.78
0.15
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
77
0.78
0.15
1.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
79
0.76
0.15
1.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
83
1.21
0.15
1.3
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
78
1.16
0.15
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
418
0.93
0.14
1.8
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
137
1327
1.04
0.13
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
48
452
1.07
0.13
4.3
3.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
113
1.15
0.13
1.8
1.4
—
—
—
0
0
(4035726)
44
465
0.94
0.11
1.4
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
212
1.09
0.10
2.2
2.9
mmol/l
1.2
1.0
0.14
13
156
(40768793) Breast Pathology biopsy report
25
232
1.08
0.10
1.1
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
30
320
0.94
0.10
1.2
1.2
u/l
15.1
12.5
0.37
22
261
(40768441) Liver Pathology biopsy report
5
46
1.09
0.09
1.0
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
629
6254
1.03
0.09
3.4
3.0
mmol/l
1.2
1.2
0.85
604
5997
(3005322) IgE [Units/volume] in Serum or Plasma
59
566
1.05
0.09
1.2
1.3
u/ml
212.2
167.4
0.16
53
527
(3045424) Erythrocytes [Presence] in Urine
13
116
1.12
0.09
1.1
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
88
1.14
0.08
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
68
1.03
0.08
1.0
1.6
—
—
—
0
0
(44790048)
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.08
2.1
1.4
—
—
—
0
0
(44790049)
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
(44806118)
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
(44790047)
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
75
1.07
0.07
1.3
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
1.5
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
226
1.06
0.06
1.9
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
436
1.03
0.05
3.8
2.2
ml/min/173m2
84.5
82.1
0.16
13
160
(1761868) Lipid panel - Serum or Plasma
286
2878
0.99
0.03
2.3
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
191
1.05
0.03
1.9
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
112
1.07
0.03
1.8
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
162
1.05
0.02
2.3
2.0
—
—
—
0
0
(4010399)
37
361
1.03
0.02
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
56
553
1.01
0.01
6.8
4.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
29
285
1.02
0.00
1.4
1.4
nmol/l
0.6
0.4
0.28
22
236
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
214
0.98
0.00
2.1
1.8
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
2.0
—
0
9
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.0
—
0.4
—
0
8
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
230
1.00
0.00
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
60
1.00
0.00
1.2
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
3.7
—
0
5
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
2.7
—
7.3
—
0
6
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.8
—
0
5
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
57
0.88
0.00
1.6
2.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.4
1.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
95
0.95
0.00
2.8
2.5
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
8
80
1.00
0.00
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
74
0.95
0.00
2.0
1.8
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
84
0.95
0.00
1.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.0
—
262.7
—
0
6
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
41.2
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
65
0.92
0.00
1.2
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
81.5
—
0
6
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
19.4
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
67
0.89
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_MATERN_INFECT_ELSEWHERE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| O15_MATERN_INFECT_ELSEWHERE | 2.082 [1.65, 2.62] | < 0.001 |
| Birth year | 0.994 [0.98, 1.0] | 0.195 |
During the follow-up period (1.1.1998 — 31.12.2019), 91 out of 5032 females with O15_MATERN_INFECT_ELSEWHERE died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have O15_MATERN_INFECT_ELSEWHERE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.203% | No data |
| 5 | 1.09% | No data |
| 10 | 2.947% | No data |
| 15 | 5.379% | No data |
| 20 | 9.454% | No data |
Relationships between endpoints
↥Index endpoint: O15_MATERN_INFECT_ELSEWHERE – Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data